Predicting Harms and Benefits in Translational Trials: Ethics, Evidence, and Uncertainty

Author:

Kimmelman Jonathan,London Alex John

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference49 articles.

1. Gene transfer and the ethics of first-in-human research: lost in translation.;J Kimmelman,2010

2. Alzheimer's failure raises questions about disease-modifying strategies.;A Extance;Nat Rev Drug Discov,2010

3. The Belmont report: ethical principles and guidelines for the protection of human subjects of research.,1979

4. Declaration of Helsinki.,1964

5. ASSERT: a standard for the review and monitoring of randomized clinical trials.;H Mann,2010

Cited by 79 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Drug testing;Translational Orthopedics;2024

2. Recombinant DNA technology and gene therapy;Biochemical and Molecular Pharmacology in Drug Discovery;2024

3. States of Uncertainty, Risk–Benefit Assessment and Early Clinical Research: A Conceptual Investigation;Science and Engineering Ethics;2022-12

4. Responsible innovation in neurology;The Lancet Neurology;2022-09

5. Ethical challenges for a new generation of early-phase pediatric gene therapy trials;Genetics in Medicine;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3